INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures

PHASE4RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 23, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2027

Conditions
Rib Fractures
Interventions
DRUG

Ropivacaine

Patients in this group will receive CINB (continuous local intercostal infusion of 0.2% Ropivacaine). A single catheter will be placed for short segment involvement and two catheters will be placed in series for longer segments of involvement. If necessary and as part of standard of care, CINB treatment will continue after patient discharge. The administration of CINB therapy will continue in the same manner as inpatient therapy.

DRUG

Non steroidal anti-inflammatory drug and opioids

Patients in this group receive nonsteroidal and opioid pain medications (intravenous/oral inpatient and oral outpatient) per standard of care.

Trial Locations (1)

40536

RECRUITING

University of Kentucky Medical Center, Lexington

All Listed Sponsors
lead

Zachary Warriner

OTHER